FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma.

World J Gastrointest Surg · 2024 · PMC11230022 · PMID 38983344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

And more validation was obtained in the external The Gene Expression Omnibus (GEO) datasets GSE26942 , GSE54129 , and GSE66229 , culminating in the screening of FDX1 as a highly significant gene.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.